[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts

INTRODUCTION: APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) is a tracer used to ass...

詳細記述

保存先:
書誌詳細
主要な著者: Munk Jensen, Mette, Erichsen, Kamille Dumong, Johnbeck, Camilla Bardram, Björkling, Fredrik, Madsen, Jacob, Bzorek, Michael, Jensen, Peter Buhl, Højgaard, Liselotte, Sehested, Maxwell, Kjær, Andreas
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537726/
https://ncbi.nlm.nih.gov/pubmed/23308217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0053410
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料